Jolien Mr Van der Meer
4PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 07, 2021
CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice.Jolien M R Van der Meer, Paul K J D de Jonge, Anniek B van der Waart
|Sep 15, 2021
Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells.J M R Van der Meer, R J A Maas, K Guldevall
|Nov 23, 2020
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer.Ralph Ja Maas, Janneke S Hoogstad-van Evert, Jolien Mr Van der Meer
|Nov 03, 2020
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells.J M R Van der Meer, R J A Maas, K Guldevall
Pageof 1
Frequent Collaborators
4 joint publications
Ralph Ja Maas
4 joint publications
Janneke S Hoogstad-van Evert
4 joint publications
Harry Dolstra
4 joint publications
Willemijn Hobo
4 joint publications
Nicolaas Pm Schaap
4 joint publications
Joop H Jansen
3 joint publications
Anniek B van der Waart
2 joint publications
K Guldevall
2 joint publications
J Cany
2 joint publications
J T Safrit
